Article Archive

Article Archive

ElevateBio Announces Presentation on Lentiviral Vector Platform at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

May 4, 2022
Read moreRead more

ElevateBio Announces Andrew Sandford Joins as President of ElevateBio BaseCamp

January 19, 2022
Read moreRead more

ElevateBio to Present at the 40th Annual J.P. Morgan Healthcare Conference

January 6, 2022
Read moreRead more

ElevateBio Announces Issuance of U.S. Patent Providing Protection for RNA-Guided Nucleases Identified through its Life Edit Gene Editing Platform

November 15, 2021
Read moreRead more

ElevateBio Supercharges Gene Editing and Therapeutic Product Development Capabilities Through Acquisition of Life Edit Therapeutics

October 27, 2021
Read moreRead more

Boston Children’s Hospital and ElevateBio Announce Five-Year Cell and Gene Therapy Collaboration

June 29, 2021
Read moreRead more

ElevateBio Announces Margo Roberts, Ph.D. Joins as Scientific Advisor for Company’s Immunotherapy Platform Expansion

June 10, 2021
Read moreRead more

ElevateBio’s BaseCamp Selected as the 2021 Facility of the Year Award Category Winner for Operational Excellence by the International Society for Pharmaceutical Engineering

April 27, 2021
Read moreRead more

ElevateBio Announces Chief Scientific Officer of Regenerative Medicine, Melissa Carpenter, PhD, Elected to the International Society for Stem Cell Research Board of Directors

March 18, 2021
Read moreRead more

ElevateBio Scales Disruptive Cell and Gene Therapy Business Model with $525 Million Series C Financing

March 15, 2021
Read moreRead more

39th Annual J.P. Morgan Healthcare Conference

Webcast Event
Read moreRead more

ElevateBio’s HighPassBio Presents on Novel T Cell Receptor Cell Therapy for Leukemia Relapse at 62nd Annual ASH Meeting

December 6, 2020
Read moreRead more

Piper Sandler 32nd Annual Virtual Healthcare Conference

Webcast Event
Read moreRead more

ElevateBio to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference

November 23, 2020
Read moreRead more

ElevateBio and AgBiome Announce LifeEDIT Will Join ElevateBio’s Portfolio of Innovative Cell and Gene Therapy Companies

November 16, 2020
Read moreRead more

AlloVir Expands Its Research Collaboration with Baylor College of Medicine to Discover and Develop Allogeneic, Off-the-Shelf, Virus-Specific T-Cell Therapies for COVID-19

March 23, 2020
Read moreRead more

AlloVir to Present at the SVB Leerink 9th Annual Global Healthcare Conference

February 19, 2020
Read moreRead more

AlloVir Receives the European Medicines Agency PRIME Designation for Viralym-M, an Allogeneic, Off-the-Shelf, Multi-Virus Specific T-Cell Therapy

February 12, 2020
Read moreRead more

ElevateBio Appoints Melissa K. Carpenter, Ph.D., as Chief Scientific Officer of Regenerative Medicine

December 9, 2019
Read moreRead more

ElevateBio Launches HighPassBio to Advance Novel Targeted T Cell Immunotherapies with Technology from Fred Hutchinson Cancer Research

October 1, 2019
Read moreRead more

Phase I Study of “Off-The-Shelf” Virus-Specific T Cells Published in BLOOD ADVANCES

September 10, 2019
Read moreRead more

Massachusetts General Hospital and ElevateBio Announce a 10-Year Alliance Agreement to Utilize ElevateBio BaseCamp to Manufacture Innovative Cell and Gene Therapies

July 25, 2019
Read moreRead more

AlloVir Announces Viralym-M Granted Regenerative Medicine Advanced Therapy (RMAT) Designation for the Treatment of Hemorrhagic Cystitis Caused by BK Virus in Adults and Children Following Allogeneic HSCT

June 11, 2019
Read moreRead more

ElevateBio announces that allovir joins its portfolio of highly innovative cell and gene therapy companies

May 22, 2019
Read moreRead more

ElevateBio Launches to Create and Operate a Portfolio of Highly Innovative Cell and Gene Therapy Companies

May 13, 2019
Read moreRead more

ElevateBio Appoints Kareem Reda as Chief Business Officer

March 5, 2020
Read moreRead more

European Medicines Agency Grants Orphan Drug Designation to AlloVir’s Viralym-M, an Allogeneic, Off-the-Shelf, Multi-Virus Specific T-Cell Therapy

March 26, 2020
Read moreRead more

ElevateBio Closes $170 Million Series B Financing

March 30, 2020
Read moreRead more

ElevateBio to Present at the Jefferies Virtual Healthcare Conference

May 26, 2020
Read moreRead more

ElevateBio to Present at the Morgan Stanley 18th Annual Global Healthcare Conference

August 25, 2020
Read moreRead more

Morgan Stanley 18th Annual Global Healthcare Conference

Webcast Event
Read moreRead more